Title:
Oral use inactivation Maiko bacteria for tuberculosis control
Document Type and Number:
Japanese Patent JP6159396
Kind Code:
B2
Abstract:
The invention relates to inactivated mycobacteria for oral use in the prevention of tuberculosis, which are administered using a multi-dose regimen and with a reduced time interval between doses, such as to induce a tolerance-building to infection by the tubercle bacillus. The inactivated bacteria can be used with the aforementioned regimen to control the progression of the infection from a latent state to active tuberculosis.
Inventors:
Cardona Iglesias, Pele-Joao
Villaplana Massa Guerre, Christina
Marzo Escartin, Elena
Villaplana Massa Guerre, Christina
Marzo Escartin, Elena
Application Number:
JP2015516652A
Publication Date:
July 05, 2017
Filing Date:
June 13, 2013
Export Citation:
Assignee:
Fundacio Institut Per Arnave Estigasio Essence De La Salute "Germans Trias I Puyol" (Ig TIP)
Cyber de Enfermedades Respiratrias (Cybers)
Cyber de Enfermedades Respiratrias (Cybers)
International Classes:
A61K39/04; A61K9/20; A61K9/48; A61P31/06
Foreign References:
| WO2011008735A1 |
Other References:
DLUGOVITZKY, D. et al.,Immunotherapy,2010年,Vol.2, No.2,p.159-69
谷野裕一,外7名,BCG免疫療法研究会会誌,1989年,第13巻,p.83-7
LEVINE, M.M. et al.,Lancet,1987年,Vol.1, No.8541,p.1049-52
谷野裕一,外7名,BCG免疫療法研究会会誌,1989年,第13巻,p.83-7
LEVINE, M.M. et al.,Lancet,1987年,Vol.1, No.8541,p.1049-52
Attorney, Agent or Firm:
Hirofumi Mimata
Previous Patent: Transition metal compound hydroxide particles, the manufacturing method and the quality for nonaqueo...
Next Patent: JPS6159397
Next Patent: JPS6159397